Hedge Fund - Marble Arch Investments
Valeant Pharmaceuticals Intl Inc (VRX)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2016 - Q1 (2016-03-31) | $0 | 0% | 0 | $73.95 |
2 | 2015 - Q4 (2015-12-31) | $94,545,000 | 6.38% | 930,100 | $112.55 |
3 | 2015 - Q3 (2015-09-30) | $213,503,000 | 16.43% | 1,196,900 | $233.19 |
4 | 2015 - Q2 (2015-06-30) | $237,478,000 | 20.47% | 1,069,000 | $221.70 |
5 | 2015 - Q1 (2015-03-31) | $212,325,000 | 18.89% | 1,069,000 | $177.40 |
6 | 2014 - Q4 (2014-12-31) | $155,489,000 | 14.91% | 1,086,500 | $134.50 |
7 | 2014 - Q3 (2014-09-30) | $135,792,000 | 11.28% | 1,035,000 | $119.20 |
8 | 2014 - Q2 (2014-06-30) | $138,568,000 | 10.24% | 1,098,700 | $127.57 |
9 | 2014 - Q1 (2014-03-31) | $177,575,000 | 13.72% | 1,347,000 | $136.73 |
10 | 2013 - Q4 (2013-12-31) | $158,138,000 | 12.4% | 1,347,000 | $109.57 |
11 | 2013 - Q3 (2013-09-30) | $140,533,000 | 11.45% | 1,347,000 | $97.42 |
12 | 2013 - Q2 (2013-06-30) | $115,950,000 | 8.88% | 1,347,000 | $78.80 |
13 | 2013 - Q1 (2013-03-31) | $67,518,000 | 4.93% | 900,000 | $67.20 |
14 | 2012 - Q4 (2012-12-31) | $40,644,000 | 3.45% | 680,000 | $56.68 |
15 | 2012 - Q3 (2012-09-30) | $37,584,000 | 3.38% | 680,000 | $51.17 |
16 | 2012 - Q1 (2012-03-31) | $61,744,000 | 7.42% | 1,150,000 | $50.92 |
17 | 2011 - Q4 (2011-12-31) | $66,533,000 | 12% | 1,425,000 | $41.70 |
18 | 2011 - Q3 (2011-09-30) | $52,896,000 | 11.73% | 1,425,000 | $45.53 |
19 | 2011 - Q2 (2011-06-30) | $72,744,000 | 13.03% | 1,400,000 | $51.68 |
20 | 2011 - Q1 (2011-03-31) | $69,734,000 | 14.22% | 1,400,000 | $39.01 |
21 | 2010 - Q4 (2010-12-31) | $27,583,000 | 7.4% | 975,000 | $26.65 |
The displayed share prices are average quarterly stock market prices.